FDA clears cord blood products from SynGen

07/16/2013 | American City Business Journals

The FDA has cleared SynGen to market a trio of devices that work in tandem to collect bone marrow or cord blood quickly enough so they can be used in the operating room in 15 minutes. The clearance applies to the company's SynGenXTM-1000 System, SynGen DataTrak software and CryoPRO-2TM Cryopreservation/Storage Bag Set.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX